Emile Loria
Voorzitter bij Portable Genomics, Inc.
Vermogen: 16 M $ op 30-04-2024
Actieve functies van Emile Loria
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Portable Genomics, Inc. | President | - | - |
Voorzitter | - | - | |
Directeur/Bestuurslid | - | - | |
Dendrogenix SA
Dendrogenix SA Pharmaceuticals: MajorHealth Technology Dendrogenix SA is a Belgian Belgium-based biotech company founded in 2018 that designs, develops, and brings proprietary molecules called dendrogenins to patients in the fields of hearing loss and neurology. The company is based in Liege, Belgium. Dendrogenins are cholesterol derivatives that stimulate cell differentiation in the immune and nervous system and induce growth of dendrites on dendritic cell and neuron precursors. The company has developed strong know-how in the chemical and biological aspects of dendrogenins. The company was founded by Stéphane Silvente, Gérard Tobelem, and Philippe Lefèbvre, with Stéphane Silvente serving as CEO since 2018. | Voorzitter | - | - |
Loopbaan van Emile Loria
Eerdere bekende functies van Emile Loria
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
OSE IMMUNOTHERAPEUTICS | Voorzitter | 27-04-2012 | 03-01-2018 |
Oprichter | 27-04-2012 | 03-01-2018 | |
IDM Pharma, Inc.
IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology IDM Pharma, Inc. develops products for the destruction of cancer cells. Its products activate the immune system or prevent recurrence by triggering adaptive immune response. The company was founded in established on October 1987 and is headquartered in Cambridge, MA. | President | 01-06-2001 | 09-01-2006 |
Epimmune, Inc. | President | 01-06-2001 | 17-08-2005 |
Ms Medical Synergy SA
Ms Medical Synergy SA Pharmaceuticals: MajorHealth Technology Ms Medical Synergy SA develops pharmaceutical products. It provides materials and products for the medical industry. The firm also offers seminars for the pharmaceutical area. The company was founded on February 3, 1986 and is headquartered in Geneva, Switzerland. | Oprichter | 01-01-1986 | - |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Biovector Therapeutics SA
Biovector Therapeutics SA Pharmaceuticals: MajorHealth Technology Biovector Therapeutics SA develops products for the prevention and treatment of infectious diseases and cancer. The private company is based in Labege, France. and has subsidiaries in France. | Corporate Officer/Principal | - | - |
SANOFI | Corporate Officer/Principal | - | - |
░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░ | ░░░░░░░░░░ | - |
Statistieken
Internationaal
Verenigde Staten | 5 |
Frankrijk | 5 |
Zwitserland | 2 |
Operationeel
Chairman | 4 |
President | 3 |
Founder | 3 |
Sectoraal
Health Technology | 9 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
SANOFI | Commercial Services |
OSE IMMUNOTHERAPEUTICS | Health Technology |
Bedrijven in privébezit | 8 |
---|---|
Epimmune, Inc. | Health Technology |
IDM Pharma, Inc.
IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology IDM Pharma, Inc. develops products for the destruction of cancer cells. Its products activate the immune system or prevent recurrence by triggering adaptive immune response. The company was founded in established on October 1987 and is headquartered in Cambridge, MA. | Health Technology |
Orphan Synergy Europe-Pharma SA
Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Orphan Synergy Europe-Pharma SA engages in the development of immunotherapy products against late stage cancer. Its products include Tedopi as treatment for lung cancer and Memopi technology which helps the immune system to eliminate malignant cells. The company was founded by Dominique Costantini and Emile Loria on November 17, 2004 and is headquartered in Paris, France. | Health Technology |
Biovector Therapeutics SA
Biovector Therapeutics SA Pharmaceuticals: MajorHealth Technology Biovector Therapeutics SA develops products for the prevention and treatment of infectious diseases and cancer. The private company is based in Labege, France. and has subsidiaries in France. | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Portable Genomics, Inc. | |
Ms Medical Synergy SA
Ms Medical Synergy SA Pharmaceuticals: MajorHealth Technology Ms Medical Synergy SA develops pharmaceutical products. It provides materials and products for the medical industry. The firm also offers seminars for the pharmaceutical area. The company was founded on February 3, 1986 and is headquartered in Geneva, Switzerland. | Health Technology |
Dendrogenix SA
Dendrogenix SA Pharmaceuticals: MajorHealth Technology Dendrogenix SA is a Belgian Belgium-based biotech company founded in 2018 that designs, develops, and brings proprietary molecules called dendrogenins to patients in the fields of hearing loss and neurology. The company is based in Liege, Belgium. Dendrogenins are cholesterol derivatives that stimulate cell differentiation in the immune and nervous system and induce growth of dendrites on dendritic cell and neuron precursors. The company has developed strong know-how in the chemical and biological aspects of dendrogenins. The company was founded by Stéphane Silvente, Gérard Tobelem, and Philippe Lefèbvre, with Stéphane Silvente serving as CEO since 2018. | Health Technology |
- Beurs
- Insiders
- Emile Loria
- Ervaring